speb/financial-data huggingface dataset:
Financial ratios for BCU.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -4215.151515151515
Operating income: -920290.9090909091
Net income: -918571.9696969696
Capital expenditures: 427709.0909090909
Operating cash flow: -227396.9696969697
Depreciation & amortization: 4215.151515151515
Net tangible assets: 7118338.636363636
Owner earnings: -1342065.909090909
Return on net tangible assets (%): -18.853639559026316
Buffett classification: The Gruesome
Stock price: 0.09848484848484848
Shares outstanding: 144760364
Book value: 7118338.636363637
P/B ratio: 2.0028131904714317
Market cap (USD): 14256702.515151514
Debt to equity: 0
Current ratio: 0.017218472943057152
Quick ratio: 0.017218472943057152
Free cash flow (dilution-adjusted): -692410.6060606061
Buyback yield (%): 0
Retained earnings: -52183407.57575757
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.698858718422828
Rule of 40 score: 0
Financial ratios for BCU.V — quarterly report dated 2024-09-30
Capital expenditures: 59757.777777777774
Buffett classification: The Gruesome
Stock price: 0.037037037037037035
Shares outstanding: 144760364
Market cap (USD): 5361494.962962963
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCU.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -1007.6923076923077
Operating income: -72507.69230769231
Net income: -85960.83916083917
Capital expenditures: 0
Operating cash flow: 92648.95104895106
Depreciation & amortization: 1227.2727272727273
Net tangible assets: 6935737.062937063
Owner earnings: -84733.56643356645
Return on net tangible assets (%): -1.2216951949687158
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 144760364
Book value: 6935737.062937062
P/B ratio: 0.5838227306348069
Market cap (USD): 4049240.9510489516
Debt to equity: 0
Current ratio: 0.009672229479514901
Quick ratio: 0.009672229479514901
Free cash flow (dilution-adjusted): 92648.95104895106
Buyback yield (%): 0
Retained earnings: -48574748.951048955
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0262969413607388
Rule of 40 score: 0
Financial ratios for BCU.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -3948.951048951049
Operating income: -390023.7762237762
Net income: -405449.65034965036
Capital expenditures: 0
Operating cash flow: -167200
Depreciation & amortization: 3948.951048951049
Net tangible assets: 6935737.062937063
Owner earnings: -401500.6993006993
Return on net tangible assets (%): -5.788868517611833
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 144760364
Book value: 6935737.062937062
P/B ratio: 0.5838227306348069
Market cap (USD): 4049240.9510489516
Debt to equity: 0
Current ratio: 0.009672229479514901
Quick ratio: 0.009672229479514901
Free cash flow (dilution-adjusted): -226829.37062937062
Buyback yield (%): 0
Retained earnings: -48574748.951048955
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.5205205938399615
Rule of 40 score: 0
Financial ratios for BCU.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -1034.2657342657344
Operating income: -82724.47552447552
Net income: -82511.88811188811
Capital expenditures: 0
Operating cash flow: 12825.874125874127
Depreciation & amortization: 1041.958041958042
Net tangible assets: 6848947.552447553
Owner earnings: -81469.93006993007
Return on net tangible assets (%): -1.189524805761081
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 144760364
Book value: 6848947.552447554
P/B ratio: 0.5912209021956821
Market cap (USD): 4049240.9510489516
Debt to equity: 0
Current ratio: 0.010894907123548625
Quick ratio: 0.010894907123548625
Free cash flow (dilution-adjusted): 12825.874125874127
Buyback yield (%): 0
Retained earnings: -48657260.839160845
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1854912609403598
Rule of 40 score: 0
Financial ratios for BCU.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -1040.875912408759
Operating income: -96936.49635036495
Net income: -82514.59854014598
Capital expenditures: 0
Operating cash flow: 32299.999999999996
Depreciation & amortization: 1032.846715328467
Net tangible assets: 6815521.897810219
Owner earnings: -81481.7518248175
Return on net tangible assets (%): -1.1955320963901097
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
Shares outstanding: 144760364
Book value: 6815521.897810218
P/B ratio: 0.9302104888315798
Market cap (USD): 6339869.956204379
Debt to equity: 0
Current ratio: 0.005810009965498833
Quick ratio: 0.005810009965498833
Free cash flow (dilution-adjusted): -11001.459854014598
Buyback yield (%): 0
Retained earnings: -50870750.3649635
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.396088915819527
Rule of 40 score: 0
Financial ratios for BCU.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -1021.5827338129498
Operating income: -337118.70503597124
Net income: -344194.96402877703
Capital expenditures: 142249.64028776978
Operating cash flow: -143781.29496402878
Depreciation & amortization: 1214.3884892086332
Net tangible assets: 6714960.431654677
Owner earnings: -485230.21582733816
Return on net tangible assets (%): -7.226106851500382
Buffett classification: The Gruesome
Stock price: 0.04316546762589928
Shares outstanding: 144760364
Book value: 6714960.431654677
P/B ratio: 0.9305563106967745
Market cap (USD): 6248648.805755396
Debt to equity: 0
Current ratio: 0.009798514445331643
Quick ratio: 0.009798514445331643
Free cash flow (dilution-adjusted): -349066.18705035973
Buyback yield (%): 0
Retained earnings: -50482992.086330935
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.926043901968788
Rule of 40 score: 0
Financial ratios for BCU.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -4205.839416058394
Operating income: -603675.1824817518
Net income: -585802.9197080291
Capital expenditures: 0
Operating cash flow: 382375.1824817518
Depreciation & amortization: 4205.839416058394
Net tangible assets: 6669175.912408759
Owner earnings: -581597.0802919707
Return on net tangible assets (%): -8.720673857317864
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 144760364
Book value: 6669175.912408758
P/B ratio: 0.7921855762829123
Market cap (USD): 5283224.963503649
Debt to equity: 0
Current ratio: 0.0052378462710600355
Quick ratio: 0.0052378462710600355
Free cash flow (dilution-adjusted): 130791.97080291968
Buyback yield (%): 0
Retained earnings: -51287913.13868613
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.88060949972393
Rule of 40 score: 0
Financial ratios for BCU.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -1048.905109489051
Operating income: -78351.09489051094
Net income: -67943.06569343065
Capital expenditures: 0
Operating cash flow: 482567.88321167877
Depreciation & amortization: 853.2846715328467
Net tangible assets: 6669175.912408759
Owner earnings: -67089.7810218978
Return on net tangible assets (%): -1.005968082159441
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 144760364
Book value: 6669175.912408758
P/B ratio: 0.7921855762829123
Market cap (USD): 5283224.963503649
Debt to equity: 0
Current ratio: 0.0052378462710600355
Quick ratio: 0.0052378462710600355
Free cash flow (dilution-adjusted): 482567.88321167877
Buyback yield (%): 0
Retained earnings: -51287913.13868613
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1526156744392513
Rule of 40 score: 0
Financial ratios for BRWM.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06243243243243243
Shares outstanding: 186379036
Market cap (USD): 11636096.571891893
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRWM.L — annual report dated 2022-12-31
Total revenue: 249097590.36144578
Net income: 243879518.07228917
Capital expenditures: 0
Operating cash flow: 62619277.10843374
Net tangible assets: 1565403614.4578314
Owner earnings: 243879518.07228917
Return on net tangible assets (%): 15.579337866595857
Buffett classification: The Gruesome
Stock price: 0.07012048192771085
P/E ratio: 0.05358788605473768
Shares outstanding: 186379036
Book value: 1565403614.4578314
P/B ratio: 0.008348637824033988
Market cap (USD): 13068987.82554217
Debt to equity: 0.12220798362176119
Effective tax rate (%): 1.5878572192565368
COGS to revenue (%): 0
SG&A to revenue (%): 0.5417144294344405
Free cash flow (dilution-adjusted): 62619277.10843374
Buyback yield (%): 0
Receivables turnover: 206750.99999999997
Capitalized R&D asset: 0
FCF margin (%): 25.138451567344294
Rule of 40 score: 25.138451567344294
Financial ratios for BRWM.L — annual report dated 2023-12-31
Total revenue: -94956962.02531645
Net income: -99981012.65822785
Capital expenditures: 0
Operating cash flow: 64402531.645569615
Net tangible assets: 1468418987.341772
Owner earnings: -99981012.65822785
Return on net tangible assets (%): -6.808752373818047
Buffett classification: The Gruesome
Stock price: 0.06594936708860759
Shares outstanding: 186379036
Book value: 1468418987.341772
P/B ratio: 0.008370621443022763
Market cap (USD): 12291579.462784808
Debt to equity: 0.1291563905380022
Free cash flow (dilution-adjusted): 64402531.645569615
Buyback yield (%): 0
Receivables turnover: -182.9658536585366
Capitalized R&D asset: 0
Revenue growth (%): -138.12038562377577
Rule of 40 score: -138.12038562377577
Financial ratios for BRWM.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1218998750
Buffett classification: The Gruesome
Stock price: 0.056874999999999995
Shares outstanding: 186379036
Book value: 1218998750
P/B ratio: 0.008695913488426464
Market cap (USD): 10600307.6725
Debt to equity: 0.13919517965051237
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRWM.L — annual report dated 2024-12-31
Total revenue: -143905000
Net income: -149926250
Capital expenditures: 0
Operating cash flow: 123965000
Net tangible assets: 1218998750
Owner earnings: -149926250
Return on net tangible assets (%): -12.299130741520448
Buffett classification: The Gruesome
Stock price: 0.056874999999999995
Shares outstanding: 186379036
Book value: 1218998750
P/B ratio: 0.008695913488426464
Market cap (USD): 10600307.6725
Debt to equity: 0.13919517965051237
Free cash flow (dilution-adjusted): 123965000
Buyback yield (%): 10.306304625800946
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRWM.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1387365753.4246576
Buffett classification: The Gruesome
Stock price: 0.07013698630136987
Shares outstanding: 186379036
Market cap (USD): 13072063.894794522
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAF.V — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.10569105691056911
Shares outstanding: 47426195
Market cap (USD): 5012524.674796748
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAF.V — annual report dated 2022-10-31
Total revenue: 16321127.941176469
Gross profit: 1728325.7352941176
Operating income: 1190336.7647058822
Net income: 1022234.5588235293
Capital expenditures: 189302.20588235292
Operating cash flow: 1532242.6470588234
Depreciation & amortization: 158334.5588235294
Net tangible assets: 5039560.294117646
Owner earnings: 991266.9117647059
Return on net tangible assets (%): 19.669710330120424
Capex to operating income (%): 15.903247845085858
Buffett classification: The Great
Stock price: 0.07352941176470588
P/E ratio: 3.41136991553251
Shares outstanding: 47426195
Book value: 5383416.176470588
P/B ratio: 0.647770877501521
Market cap (USD): 3487220.220588235
Debt to equity: 0.008874203265311251
Current ratio: 2.525741488093978
Quick ratio: 2.0855583060737337
Effective tax rate (%): 29.02960845372403
Interest coverage ratio: 39.719753661947635
COGS to revenue (%): 89.41050066194424
SG&A to revenue (%): 3.2962732265026022
Free cash flow (dilution-adjusted): 1342940.4411764706
Buyback yield (%): 0
Retained earnings: -1428744.1176470588
Inventory turnover: 14.035400714704483
Receivables turnover: 7.346674032073944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.968215351362144
FCF margin (%): 8.228233036445813
Rule of 40 score: 8.228233036445813
Financial ratios for CAF.V — annual report dated 2023-10-31
Total revenue: 23424787.68115942
Gross profit: 2858508.6956521743
Operating income: 2191417.391304348
Net income: 2128030.434782609
Capital expenditures: 43671.739130434784
Operating cash flow: 1525695.652173913
Depreciation & amortization: 161858.69565217392
Net tangible assets: 6582585.507246377
Owner earnings: 2246217.391304348
Return on net tangible assets (%): 34.12363407709054
Capex to operating income (%): 1.992853543269593
Buffett classification: The Great
Stock price: 0.13043478260869565
P/E ratio: 2.9069252646353942
Shares outstanding: 47426195
Book value: 7314696.376811596
P/B ratio: 0.8456981829612231
Market cap (USD): 6186025.434782608
Debt to equity: 0.004703554418586128
Current ratio: 3.190818173469974
Quick ratio: 2.7521872628254145
Effective tax rate (%): 17.470612056665637
Interest coverage ratio: 215.9957145918149
COGS to revenue (%): 87.79707746102102
SG&A to revenue (%): 2.8478008570569386
Free cash flow (dilution-adjusted): 1482023.9130434783
Buyback yield (%): 0
Retained earnings: 213918.84057971017
Inventory turnover: 18.51042772011956
Receivables turnover: 7.9751886527356275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.874326849766558
FCF margin (%): 6.326733600388068
Revenue growth (%): 43.52431869651102
Rule of 40 score: 49.851052296899084
Financial ratios for CAF.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.22302158273381295
Shares outstanding: 47426195
Market cap (USD): 10577065.071942447
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAF.V — annual report dated 2024-10-31
Total revenue: 23557372.661870506
Gross profit: 2558374.1007194244
Operating income: 1906422.3021582735
Net income: 1790615.8273381295
Capital expenditures: 129779.85611510792
Operating cash flow: 2182921.582733813
Depreciation & amortization: 147782.73381294965
Net tangible assets: 8603492.805755395
Owner earnings: 1808618.7050359712
Return on net tangible assets (%): 21.021912214839965
Capex to operating income (%): 6.807508282303626
Buffett classification: The Great
Stock price: 0.22302158273381295
P/E ratio: 5.906942690027465
Shares outstanding: 47426195
Book value: 9493576.258992806
P/B ratio: 1.1141286258614402
Market cap (USD): 10577065.071942447
Debt to equity: 0.0023133400843326777
Current ratio: 4.855589361226864
Quick ratio: 4.38706393893412
Effective tax rate (%): 26.21476537125687
Interest coverage ratio: 210.7465404803563
COGS to revenue (%): 89.1398156431071
SG&A to revenue (%): 2.767506410493677
Free cash flow (dilution-adjusted): 2053141.726618705
Buyback yield (%): 0
Retained earnings: 1767256.8345323743
Inventory turnover: 23.99303601593036
Receivables turnover: 9.12403008542855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.068040862988912
FCF margin (%): 8.715495382648845
Revenue growth (%): 0.5660029133058998
Rule of 40 score: 9.281498295954744
Financial ratios for CAF.V — quarterly report dated 2025-01-31
Total revenue: 5801043.448275862
Gross profit: 733246.8965517242
Operating income: 579476.551724138
Net income: 538761.3793103448
Capital expenditures: 1721.3793103448277
Operating cash flow: 1528303.448275862
Depreciation & amortization: 42482.06896551724
Net tangible assets: 8574028.965517242
Owner earnings: 579522.0689655172
Return on net tangible assets (%): 6.75904025162757
Capex to operating income (%): 0.2970576298942803
Buffett classification: The Great
Stock price: 0.26896551724137935
P/E ratio: 5.919137654825117
Shares outstanding: 47426195
Book value: 9484511.72413793
P/B ratio: 1.3449307080829134
Market cap (USD): 12756011.068965519
Debt to equity: 0.002181196756206962
Current ratio: 4.092240338778374
Quick ratio: 3.699404801684827
Effective tax rate (%): 26.2181219907027
Interest coverage ratio: 328.09098008590394
COGS to revenue (%): 87.36008611054872
SG&A to revenue (%): 2.650735961532723
Free cash flow (dilution-adjusted): 1526582.0689655172
Buyback yield (%): 0
Retained earnings: 2160720.6896551726
Inventory turnover: 5.435297641942069
Receivables turnover: 2.0534957834007783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.105944670428787
FCF margin (%): 26.315646186363857
Rule of 40 score: 26.315646186363857
Financial ratios for CAF.V — quarterly report dated 2025-04-30
Total revenue: 3937018.8405797104
Gross profit: 413619.56521739135
Operating income: 224306.52173913046
Net income: 318797.1014492754
Capital expenditures: 21355.072463768116
Operating cash flow: -650381.8840579711
Depreciation & amortization: 44878.98550724638
Net tangible assets: 8913414.492753623
Owner earnings: 342321.01449275366
Return on net tangible assets (%): 3.8405149314109854
Capex to operating income (%): 9.520486652904442
Buffett classification: The Great
Stock price: 0.22463768115942032
P/E ratio: 8.354616794335591
Shares outstanding: 47426195
Book value: 9788286.95652174
P/B ratio: 1.0884141952863509
Market cap (USD): 10653710.471014494
Debt to equity: 0.0021237302555346393
Current ratio: 9.497133133726427
Quick ratio: 8.603876389745638
Effective tax rate (%): 27.782674999056123
Interest coverage ratio: 135.17161572052404
COGS to revenue (%): 89.49409230776027
SG&A to revenue (%): 4.8085379101306325
Free cash flow (dilution-adjusted): -671736.9565217391
Buyback yield (%): 0
Retained earnings: 2564234.0579710146
Inventory turnover: 4.383510799902274
Receivables turnover: 1.4936290156967396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2902042593213534
FCF margin (%): -17.062071169129293
Revenue growth (%): -32.132574498302745
Rule of 40 score: -49.19464566743204
Financial ratios for CAF.V — quarterly report dated 2025-07-31
Total revenue: 4875734.057971015
Gross profit: 823992.0289855073
Operating income: 649334.0579710145
Net income: 630326.0869565218
Capital expenditures: 36386.956521739135
Operating cash flow: 597453.6231884059
Depreciation & amortization: 37671.739130434784
Net tangible assets: 9679015.217391305
Owner earnings: 631610.8695652175
Return on net tangible assets (%): 6.525569547926073
Capex to operating income (%): 5.6037344838245655
Buffett classification: The Great
Stock price: 0.2898550724637682
P/E ratio: 9.239105967411573
Shares outstanding: 47426195
Book value: 10571313.043478262
P/B ratio: 1.3003799179787356
Market cap (USD): 13746723.1884058
Debt to equity: 0.002019822308281395
Current ratio: 5.681383798134266
Quick ratio: 5.304770138448388
Effective tax rate (%): 26.86863931194223
Interest coverage ratio: 384.91451890034364
COGS to revenue (%): 83.10012925589947
SG&A to revenue (%): 3.5821882190017322
Free cash flow (dilution-adjusted): 561066.6666666667
Buyback yield (%): 0
Retained earnings: 3100702.898550725
Inventory turnover: 6.060136367626832
Receivables turnover: 1.3450601992488387
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.138907212981848
FCF margin (%): 11.507327101842563
Revenue growth (%): 23.843300106053903
Rule of 40 score: 35.350627207896466
Financial ratios for CAF.V — annual report dated 2025-10-31
Total revenue: 19767148.57142857
Gross profit: 2682208.571428572
Operating income: 1983301.4285714286
Net income: 1934385.0000000002
Capital expenditures: 92578.57142857143
Operating cash flow: 2524112.142857143
Depreciation & amortization: 152297.85714285716
Net tangible assets: 10543188.571428573
Owner earnings: 1994104.285714286
Return on net tangible assets (%): 18.913673716490212
Capex to operating income (%): 4.667902220756012
Buffett classification: The Great
Stock price: 0.2285714285714286
P/E ratio: 5.603989455489544
Shares outstanding: 47426195
Book value: 11419670.000000002
P/B ratio: 0.9492632574196226
Market cap (USD): 10840273.142857144
Debt to equity: 0
Current ratio: 6.720284096657689
Quick ratio: 6.218756623893767
Effective tax rate (%): 26.474739749413363
Interest coverage ratio: 255.4155091527918
COGS to revenue (%): 86.43097884484241
SG&A to revenue (%): 3.5357003582567446
Free cash flow (dilution-adjusted): 2431533.5714285714
Buyback yield (%): 0
Retained earnings: 3484005.7142857146
Inventory turnover: 21.83378913738019
Receivables turnover: 6.997700221683964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.367414545003736
FCF margin (%): 12.300881751569921
Revenue growth (%): -16.089332816713963
Rule of 40 score: -3.7884510651440415
Financial ratios for CAF.V — quarterly report dated 2025-10-31
Total revenue: 5120142.857142857
Gross profit: 750917.142857143
Operating income: 570043.5714285715
Net income: 440817.85714285716
Capital expenditures: 33878.57142857143
Operating cash flow: 993398.5714285715
Depreciation & amortization: 26927.14285714286
Net tangible assets: 10543188.571428573
Owner earnings: 433866.4285714286
Return on net tangible assets (%): 4.115134862969077
Capex to operating income (%): 5.943154721255643
Buffett classification: The Great
Stock price: 0.2285714285714286
P/E ratio: 5.620500603481969
Shares outstanding: 47426195
Book value: 11419670.000000002
P/B ratio: 0.9492632574196226
Market cap (USD): 10840273.142857144
Debt to equity: 0
Current ratio: 6.720284096657689
Quick ratio: 6.218756623893767
Effective tax rate (%): 25.271628901581515
Interest coverage ratio: 216.15953412784398
COGS to revenue (%): 85.33407271002484
SG&A to revenue (%): 3.5325883764403896
Free cash flow (dilution-adjusted): 959520.0000000001
Buyback yield (%): 0
Retained earnings: 3484005.7142857146
Inventory turnover: 5.58367594705614
Receivables turnover: 1.8125641478847223
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.991769214246746
FCF margin (%): 18.74010211768645
Revenue growth (%): 5.012759027992408
Rule of 40 score: 23.75286114567886
Financial ratios for CAF.V — quarterly report dated 2026-01-31
Total revenue: 4614108.888888889
Gross profit: 673997.037037037
Operating income: 454877.037037037
Net income: 439917.77777777775
Capital expenditures: 85959.25925925926
Operating cash flow: 464012.5925925926
Depreciation & amortization: 33354.07407407407
Net tangible assets: 11789645.925925925
Owner earnings: 387312.5925925925
Return on net tangible assets (%): 3.285192744770018
Capex to operating income (%): 18.897251841767577
Buffett classification: The Great
Stock price: 0.25925925925925924
P/E ratio: 6.7194692991852385
Shares outstanding: 47426195
Book value: 12644057.037037035
P/B ratio: 0.9724473837130452
Market cap (USD): 12295680.185185185
Debt to equity: 0
Current ratio: 7.044890593581101
Quick ratio: 6.492951406557884
Effective tax rate (%): 26.88680232479407
Interest coverage ratio: 205.17340461075844
COGS to revenue (%): 85.39269329642238
SG&A to revenue (%): 4.748912634629343
Free cash flow (dilution-adjusted): 378053.3333333333
Buyback yield (%): 0
Retained earnings: 3998317.037037037
Inventory turnover: 4.320754303167164
Receivables turnover: 1.320092314636935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5975562460148165
FCF margin (%): 8.193420277612288
Revenue growth (%): -9.883200183526625
Rule of 40 score: -1.689779905914337
Financial ratios for CANF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 258
Shares outstanding: 2142547
Market cap (USD): 552777126
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CANF — annual report dated 2022-12-31
Total revenue: 230113.63636363635
Operating income: -2868181.8181818184
Net income: -2890056.8181818184
Capital expenditures: 2556.818181818182
Operating cash flow: -3068465.909090909
Depreciation & amortization: 3977.2727272727275
Net tangible assets: 1270454.5454545454
Owner earnings: -2888636.3636363638
Return on net tangible assets (%): -227.37030411449018
Buffett classification: The Gruesome
Stock price: 122
Shares outstanding: 2142547
Book value: 1270454.5454545456
P/B ratio: 205.74583713774595
Market cap (USD): 261390734
Debt to equity: 0.013864042933810375
Current ratio: 3.6598721023181455
Quick ratio: 3.6598721023181455
COGS to revenue (%): 0
R&D to revenue (%): 958.395061728395
SG&A to revenue (%): 388.0246913580247
Free cash flow (dilution-adjusted): -3145738.6363636362
Buyback yield (%): 0
Retained earnings: -42854261.36363637
Receivables turnover: 17.234042553191486
Capitalized R&D asset: 2205397.727272727
ROCI (R&D-adjusted, %): -33.83296662999634
FCF margin (%): -1367.0370370370372
Rule of 40 score: -1367.0370370370372
Financial ratios for CANF — annual report dated 2023-12-31
Total revenue: 205248.61878453038
Operating income: -2263812.1546961325
Net income: -2108839.7790055247
Capital expenditures: 552.4861878453039
Operating cash flow: -2331491.7127071824
Depreciation & amortization: 4143.646408839779
Net tangible assets: 1724585.635359116
Owner earnings: -2105248.6187845306
Return on net tangible assets (%): -122.0727214480218
Buffett classification: The Gruesome
Stock price: 44
Shares outstanding: 2142547
Book value: 1724585.635359116
P/B ratio: 54.66360502322602
Market cap (USD): 94272068
Debt to equity: 0.006407176037161621
Current ratio: 4.904950495049505
Quick ratio: 4.904950495049505
COGS to revenue (%): 0
R&D to revenue (%): 805.2489905787348
SG&A to revenue (%): 397.7119784656797
Free cash flow (dilution-adjusted): -2404143.6464088396
Buyback yield (%): 0
Retained earnings: -43779281.7679558
Capitalized R&D asset: 3130378.908211954
ROCI (R&D-adjusted, %): -35.58117893191361
FCF margin (%): -1171.3324360699864
Revenue growth (%): -10.80553850351272
Rule of 40 score: -1182.1379745734992
Financial ratios for CANF — annual report dated 2024-12-31
Total revenue: 184657.53424657535
Operating income: -2227397.2602739725
Net income: -2158904.109589041
Capital expenditures: 1369.86301369863
Operating cash flow: -2092328.7671232878
Depreciation & amortization: 1917.8082191780823
Net tangible assets: 1489315.0684931506
Owner earnings: -2158356.164383562
Return on net tangible assets (%): -144.9227373068433
Buffett classification: The Gruesome
Stock price: 32.6
Shares outstanding: 2142547
Book value: 1489315.0684931506
P/B ratio: 46.898761502943344
Market cap (USD): 69847032.2
Debt to equity: 0.01913171449595291
Current ratio: 4.37719298245614
Quick ratio: 4.37719298245614
COGS to revenue (%): 0
R&D to revenue (%): 854.1543026706231
SG&A to revenue (%): 452.07715133531156
Free cash flow (dilution-adjusted): -2192876.712328767
Buyback yield (%): 0
Retained earnings: -45578356.16438356
Capitalized R&D asset: 3412392.3527018847
ROCI (R&D-adjusted, %): -46.02770083840223
FCF margin (%): -1187.5370919881304
Revenue growth (%): -10.032264606648345
Rule of 40 score: -1197.5693565947788
Financial ratios for CANF — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1489315.0684931506
Buffett classification: The Gruesome
Stock price: 32.6
Shares outstanding: 2142547
Book value: 1489315.0684931506
P/B ratio: 46.898761502943344
Market cap (USD): 69847032.2
Debt to equity: 0.01913171449595291
Current ratio: 4.37719298245614
Quick ratio: 4.37719298245614
Buyback yield (%): 0
Retained earnings: -45578356.16438356
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CANF — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1234218.2890855456
Buffett classification: The Gruesome
Stock price: 21
Shares outstanding: 2142547
Book value: 1234218.2890855456
P/B ratio: 36.45504802342257
Market cap (USD): 44993487
Debt to equity: 0.021510516252390057
Current ratio: 3.5962264150943395
Quick ratio: 3.5962264150943395
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCRN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.76
Shares outstanding: 32306484
Market cap (USD): 896827995.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCRN — annual report dated 2022-12-31
Total revenue: 2803381000
Gross profit: 624458000
Operating income: 287673000
Net income: 185982000
Capital expenditures: 8786000
Operating cash flow: 134050000
Depreciation & amortization: 12576000
Net tangible assets: 249228000
Owner earnings: 189772000
Return on net tangible assets (%): 76.14393246344713
Capex to operating income (%): 3.0541621910989214
Buffett classification: The Great
Stock price: 26.57
P/E ratio: 4.615410522953835
Shares outstanding: 32306484
Book value: 457219000
P/B ratio: 1.8774007201800451
Market cap (USD): 858383279.88
Debt to equity: 0.3450140960896201
Current ratio: 2.487384037696952
Quick ratio: 2.487384037696952
Effective tax rate (%): 26.517501195193937
Interest coverage ratio: 19.98978528246821
COGS to revenue (%): 77.72482584422168
SG&A to revenue (%): 11.56492820633371
Free cash flow (dilution-adjusted): 117871000
Buyback yield (%): 4.110634587958512
Retained earnings: 165726000
Receivables turnover: 4.247804412388629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.54265386372946
FCF margin (%): 4.204601515099089
Rule of 40 score: 4.204601515099089
Financial ratios for CCRN — annual report dated 2023-12-31
Total revenue: 2019728000
Gross profit: 450410000
Operating income: 131731000
Net income: 72631000
Capital expenditures: 13974000
Operating cash flow: 248498000
Depreciation & amortization: 18347000
Net tangible assets: 277753000
Owner earnings: 77004000
Return on net tangible assets (%): 27.723912973037194
Capex to operating income (%): 10.60798141667489
Buffett classification: The Great
Stock price: 22.64
P/E ratio: 10.070339080557888
Shares outstanding: 32306484
Book value: 467651000
P/B ratio: 1.5640270153597449
Market cap (USD): 731418797.76
Debt to equity: 0.011262672377478076
Current ratio: 2.6709743970885977
Quick ratio: 2.6709743970885977
Effective tax rate (%): 29.41182187493926
Interest coverage ratio: 16.275142080553497
COGS to revenue (%): 77.69947240420493
SG&A to revenue (%): 14.8699230787512
Free cash flow (dilution-adjusted): 227945000
Buyback yield (%): 7.882488141755138
Retained earnings: 232615000
Receivables turnover: 5.177873658250207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.092192583449524
FCF margin (%): 11.285925629589727
Revenue growth (%): -27.953852865522027
Rule of 40 score: -16.6679272359323
Financial ratios for CCRN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.44
Shares outstanding: 32306484
Market cap (USD): 434199144.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.16
Shares outstanding: 32306484
Market cap (USD): 586685749.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCRN — annual report dated 2024-12-31
Total revenue: 1344004000
Gross profit: 274252000
Operating income: 22675000
Net income: -14556000
Capital expenditures: 8714000
Operating cash flow: 120116000
Depreciation & amortization: 18200000
Net tangible assets: 241713000
Owner earnings: -5070000
Return on net tangible assets (%): -2.0975288875650047
Capex to operating income (%): 38.429988974641674
Buffett classification: The Good
Stock price: 18.16
Shares outstanding: 32306484
Book value: 418959000
P/B ratio: 1.4003416788754985
Market cap (USD): 586685749.44
Debt to equity: 0.00923956759491979
Current ratio: 2.782345808209166
Quick ratio: 2.782345808209166
Interest coverage ratio: 10.363345521023765
COGS to revenue (%): 79.59440596902986
SG&A to revenue (%): 17.364308439558215
Free cash flow (dilution-adjusted): 105377000
Buyback yield (%): 6.3594522341156114
Retained earnings: 218059000
Receivables turnover: 5.533567740713598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.836311904259154
FCF margin (%): 7.840527260335535
Revenue growth (%): -33.45618815998986
Rule of 40 score: -25.615660899654323
Financial ratios for CCRN — quarterly report dated 2025-03-31
Total revenue: 293408000
Gross profit: 58658000
Operating income: 1400000
Net income: -490000
Capital expenditures: 1886000
Operating cash flow: 5681000
Depreciation & amortization: 4772000
Net tangible assets: 243185000
Owner earnings: 2396000
Capex to operating income (%): 134.71428571428572
Buffett classification: The Gruesome
Stock price: 14.89
Shares outstanding: 32306484
Book value: 418210000
P/B ratio: 1.1502440084168242
Market cap (USD): 481043546.76
Debt to equity: 0.007914684010425384
Current ratio: 2.9821638177683223
Quick ratio: 2.9821638177683223
Interest coverage ratio: 2.578268876611418
COGS to revenue (%): 80.00804340713273
SG&A to revenue (%): 17.888401134256736
Free cash flow (dilution-adjusted): 2477000
Buyback yield (%): 0.06527475570868835
Retained earnings: 217569000
Receivables turnover: 1.248411871077545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2996658725521044
FCF margin (%): 0.8442169266005017
Rule of 40 score: 0.8442169266005017
Financial ratios for CCRN — quarterly report dated 2025-06-30
Total revenue: 274072000
Gross profit: 56004000
Operating income: 1853000
Net income: -6659000
Capital expenditures: 1967000
Operating cash flow: 4217000
Depreciation & amortization: 4101000
Net tangible assets: 239438000
Owner earnings: -4525000
Return on net tangible assets (%): -1.8898420467929067
Capex to operating income (%): 106.15218564490017
Buffett classification: The Gruesome
Stock price: 13.05
Shares outstanding: 32306484
Book value: 412242000
P/B ratio: 1.0226993275794316
Market cap (USD): 421599616.20000005
Debt to equity: 0.006714502646503752
Current ratio: 3.213809598086622
Quick ratio: 3.213809598086622
Interest coverage ratio: 3.3752276867030964
COGS to revenue (%): 79.56595347208034
SG&A to revenue (%): 18.261624682565163
Free cash flow (dilution-adjusted): 1380000
Buyback yield (%): 0
Retained earnings: 210910000
Receivables turnover: 1.2546326814619497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.40489191592756957
FCF margin (%): 0.5035173239148837
Revenue growth (%): -6.5901406914603555
Rule of 40 score: -6.086623367545472
Financial ratios for CCRN — quarterly report dated 2025-09-30
Total revenue: 250052000
Gross profit: 50927000
Operating income: -55000
Net income: -4774000
Capital expenditures: 2191000
Operating cash flow: 20114000
Depreciation & amortization: 4088000
Net tangible assets: 237559000
Owner earnings: -2877000
Return on net tangible assets (%): -1.2110675663729853
Buffett classification: The Gruesome
Stock price: 14.2
Shares outstanding: 32306484
Book value: 408142000
P/B ratio: 1.1240011388193323
Market cap (USD): 458752072.79999995
Debt to equity: 0.005400081344238035
Current ratio: 3.4498386795099596
Quick ratio: 3.4498386795099596
Interest coverage ratio: -0.09892086330935251
COGS to revenue (%): 79.633436245261
SG&A to revenue (%): 18.753699230560045
Free cash flow (dilution-adjusted): 17157000
Buyback yield (%): 0
Retained earnings: 206136000
Receivables turnover: 1.3188396624472574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.012149675161866809
FCF margin (%): 6.861372834450434
Revenue growth (%): -8.764120377127178
Rule of 40 score: -1.9027475426767433
Financial ratios for CCRN — quarterly report dated 2025-12-31
Total revenue: 236761000
Gross profit: 47982000
Operating income: -7101000
Net income: -82929000
Capital expenditures: 2117000
Operating cash flow: 18239000
Depreciation & amortization: 3833000
Net tangible assets: 231384000
Owner earnings: -81213000
Return on net tangible assets (%): -35.09879680531065
Buffett classification: The Gruesome
Stock price: 8.1
Shares outstanding: 32306484
Book value: 322822000
P/B ratio: 0.8106093153502549
Market cap (USD): 261682520.39999998
Debt to equity: 0.0071804276040666375
Current ratio: 3.775772930706312
Quick ratio: 3.775772930706312
Interest coverage ratio: -12.501760563380282
COGS to revenue (%): 79.73399335194563
SG&A to revenue (%): 21.646301544595605
Free cash flow (dilution-adjusted): 11932000
Buyback yield (%): 2.491186644807324
Retained earnings: 123207000
Receivables turnover: 1.3455616997334576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9130106817171568
FCF margin (%): 5.039681366441264
Revenue growth (%): -5.315294418760898
Rule of 40 score: -0.27561305231963384
Financial ratios for CCRN — annual report dated 2025-12-31
Total revenue: 1054293000
Gross profit: 213571000
Operating income: -3903000
Net income: -94852000
Capital expenditures: 8161000
Operating cash flow: 48251000
Depreciation & amortization: 16794000
Net tangible assets: 231384000
Owner earnings: -86219000
Return on net tangible assets (%): -37.262299899733776
Buffett classification: The Gruesome
Stock price: 8.1
Shares outstanding: 32306484
Book value: 322822000
P/B ratio: 0.8106093153502549
Market cap (USD): 261682520.39999998
Debt to equity: 0.0071804276040666375
Current ratio: 3.775772930706312
Quick ratio: 3.775772930706312
Interest coverage ratio: -1.7612815884476534
COGS to revenue (%): 79.74272806515835
SG&A to revenue (%): 19.034556807263257
Free cash flow (dilution-adjusted): 32946000
Buyback yield (%): 2.611179374745888
Retained earnings: 123207000
Receivables turnover: 5.991765033502504
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.051468904484166
FCF margin (%): 3.1249377544951926
Revenue growth (%): -21.55581382198267
Rule of 40 score: -18.43087606748748
Financial ratios for EPH.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.967032967032964
Shares outstanding: 14311816
Market cap (USD): 471818109.89010984
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPH.SW — annual report dated 2022-12-31
Total revenue: 36890020.652173914
Gross profit: 28188922.826086957
Operating income: -1153484.7826086956
Net income: 7739675
Capital expenditures: 0
Operating cash flow: 70534810.86956522
Depreciation & amortization: 10571.739130434782
Net tangible assets: 535504583.6956521
Owner earnings: 7750246.739130435
Return on net tangible assets (%): 1.4472792530820238
Buffett classification: The Gruesome
Stock price: 32.608695652173914
P/E ratio: 60.298352601874505
Shares outstanding: 14311816
Book value: 572352734.7826085
P/B ratio: 0.8153881755298531
Market cap (USD): 466689652.17391306
Debt to equity: 1.1259501485284287
Current ratio: 0.9321819881193796
Quick ratio: 0.9321819881193796
Effective tax rate (%): 47.404614080904345
Interest coverage ratio: -0.03857672325959691
COGS to revenue (%): 23.58658973961351
SG&A to revenue (%): 12.432014796979233
Free cash flow (dilution-adjusted): 70534810.86956522
Buyback yield (%): 0.037338844117802146
Retained earnings: -29427304.347826086
Receivables turnover: 7.896820058155565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.11687918189299801
FCF margin (%): 191.2029584765457
Rule of 40 score: 191.2029584765457
Financial ratios for EPH.SW — annual report dated 2023-12-31
Total revenue: 52913117.85714286
Gross profit: 38805370.23809524
Operating income: 44797705.952380955
Net income: -190778523.80952382
Capital expenditures: 0
Operating cash flow: 44367334.52380952
Depreciation & amortization: 3667.857142857143
Net tangible assets: 558943933.3333334
Owner earnings: -190774855.95238096
Return on net tangible assets (%): -34.13130451468912
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.19047619047619
Shares outstanding: 14311816
Book value: 596359655.9523809
P/B ratio: 0.7485287640351722
Market cap (USD): 446392356.1904762
Debt to equity: 0.8777328784003948
Current ratio: 0.49663559537921176
Quick ratio: 0.49663559537921176
Interest coverage ratio: 2.156689337556073
COGS to revenue (%): 26.66209853128733
SG&A to revenue (%): 10.843744099013703
Free cash flow (dilution-adjusted): 44367334.52380952
Buyback yield (%): 0.02372619138592777
Retained earnings: -223008428.57142857
Receivables turnover: 19.761292035020514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.710604428148598
FCF margin (%): 83.84940506358818
Revenue growth (%): 43.434774287730605
Rule of 40 score: 127.28417935131878
Financial ratios for EPH.SW — annual report dated 2024-12-31
Total revenue: 61093261.11111111
Gross profit: 37897067.777777776
Operating income: 36469105.55555555
Net income: -3367280
Capital expenditures: 744900
Operating cash flow: 35622487.777777776
Depreciation & amortization: 1608251.111111111
Net tangible assets: 515559724.4444444
Owner earnings: -2503928.888888889
Return on net tangible assets (%): -0.48567193482521676
Capex to operating income (%): 2.042550780043809
Buffett classification: The Great
Stock price: 22.22222222222222
Shares outstanding: 14311816
Book value: 555810201.1111109
P/B ratio: 0.572210360514734
Market cap (USD): 318040355.5555555
Debt to equity: 0.8816808689935267
Current ratio: 5.781242802191253
Quick ratio: 5.756632278312311
Interest coverage ratio: 2.0089433621746156
COGS to revenue (%): 37.96849752568636
SG&A to revenue (%): 9.741589065969904
Free cash flow (dilution-adjusted): 34877587.777777776
Buyback yield (%): 0.01565978768871819
Retained earnings: -211824356.66666666
Inventory turnover: 58.41071598444364
Receivables turnover: 99.69960797539783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.403852270275137
FCF margin (%): 57.089091568291714
Revenue growth (%): 15.459575215456706
Rule of 40 score: 72.54866678374842
Financial ratios for EPH.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 515559724.4444444
Buffett classification: The Gruesome
Stock price: 22.22222222222222
Shares outstanding: 14311816
Book value: 555810201.1111109
P/B ratio: 0.572210360514734
Market cap (USD): 318040355.5555555
Debt to equity: 0.8816808689935267
Current ratio: 5.781242802191253
Quick ratio: 5.756632278312311
Buyback yield (%): 0
Retained earnings: -211824356.66666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPH.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 583382338.75
Buffett classification: The Gruesome
Stock price: 30
Shares outstanding: 14311816
Book value: 629082218.75
P/B ratio: 0.6825093242233689
Market cap (USD): 429354480
Debt to equity: 0.87567735755526
Current ratio: 6.849116920271007
Quick ratio: 6.825142438578477
Buyback yield (%): 0
Retained earnings: -232712020
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERM.AX — annual report dated 2021-06-30
Operating income: -1383218.7969924812
Net income: -1185830.07518797
Capital expenditures: 123304.51127819548
Depreciation & amortization: 15790.977443609021
Net tangible assets: 16612883.458646616
Owner earnings: -1293343.6090225566
Return on net tangible assets (%): -7.78518438561249
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 676025455
Book value: 16612883.458646614
P/B ratio: 1.8357673442592681
Market cap (USD): 30497388.94736842
Debt to equity: 0.008730111854940013
Current ratio: 6.752586166425201
Quick ratio: 6.752586166425201
Free cash flow (dilution-adjusted): -2383824.0601503756
Buyback yield (%): 1.0203166092318223
Retained earnings: -27598401.503759395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.278358203313575
Rule of 40 score: 0
Financial ratios for ERM.AX — annual report dated 2022-06-30
Total revenue: 54731.03448275862
Gross profit: 54731.03448275862
Operating income: -1070657.2413793104
Net income: -1038800.6896551724
Capital expenditures: 26140.689655172413
Depreciation & amortization: 50220
Net tangible assets: 17647987.586206898
Owner earnings: -1014721.3793103448
Return on net tangible assets (%): -5.74978520555748
Buffett classification: The Gruesome
Stock price: 0.06206896551724138
Shares outstanding: 676025455
Book value: 22372125.51724138
P/B ratio: 1.8755571804223619
Market cap (USD): 41960200.655172415
Debt to equity: 0.003934760934959026
Current ratio: 8.4466475909956
Quick ratio: 8.4466475909956
COGS to revenue (%): 0
SG&A to revenue (%): 1508.133820564516
Free cash flow (dilution-adjusted): -2781223.4482758623
Buyback yield (%): 0.5537250401646817
Retained earnings: -26353196.55172414
Receivables turnover: 0.8745289048553104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.777310580440036
FCF margin (%): -5081.620463709677
Rule of 40 score: -5081.620463709677
Financial ratios for ERM.AX — annual report dated 2023-06-30
Operating income: -2328454.9668874172
Net income: -1712284.1059602648
Capital expenditures: 26782.11920529801
Depreciation & amortization: 47314.56953642384
Net tangible assets: 4880962.251655629
Owner earnings: -1691751.655629139
Return on net tangible assets (%): -34.66020772963967
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 676025455
Book value: 4880962.251655629
P/B ratio: 5.5034104392345835
Market cap (USD): 26861938.609271523
Debt to equity: 0.0077062483472412685
Current ratio: 7.834321105575086
Quick ratio: 7.834321105575086
Free cash flow (dilution-adjusted): -2377884.7682119207
Buyback yield (%): 0
Retained earnings: -37459488.079470195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.70483455588296
Rule of 40 score: 0
Financial ratios for ERM.AX — annual report dated 2024-06-30
Operating income: -2247462.6666666665
Net income: -1958802
Capital expenditures: 15752.666666666666
Depreciation & amortization: 51669.333333333336
Net tangible assets: 3175910
Owner earnings: -1922885.3333333335
Return on net tangible assets (%): -60.54596425381492
Buffett classification: The Gruesome
Stock price: 0.04
Shares outstanding: 676025455
Book value: 3175910
P/B ratio: 8.514415773746737
Market cap (USD): 27041018.2
Debt to equity: 0.06294133020142259
Current ratio: 4.431670602552773
Quick ratio: 4.431670602552773
Free cash flow (dilution-adjusted): -1721774.6666666667
Buyback yield (%): 0
Retained earnings: -39668020
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -67.23818159008451
Rule of 40 score: 0
Financial ratios for FGT.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.10567567567567568
Shares outstanding: 100892312
Market cap (USD): 10661863.241081081
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FGT.L — annual report dated 2022-09-30
Total revenue: -126393333.33333333
Net income: -131933333.33333333
Capital expenditures: 0
Operating cash flow: 42331111.11111111
Net tangible assets: 2033760000
Owner earnings: -131933333.33333333
Return on net tangible assets (%): -6.487163349329976
Buffett classification: The Gruesome
Stock price: 0.082
Shares outstanding: 100892312
Book value: 2033760000
P/B ratio: 0.004067918330579813
Market cap (USD): 8273169.584000001
Debt to equity: 0.020050437503824334
Free cash flow (dilution-adjusted): 42331111.11111111
Buyback yield (%): 983.8094263126399
Receivables turnover: -9.17518954670108
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FGT.L — annual report dated 2023-09-30
Total revenue: 163362195.12195122
Net income: 157143902.4390244
Capital expenditures: 0
Operating cash flow: 44993902.439024396
Net tangible assets: 2222840243.902439
Owner earnings: 157143902.4390244
Return on net tangible assets (%): 7.069509510190489
Buffett classification: The Gruesome
Stock price: 0.09670731707317073
P/E ratio: 0.06208974484781698
Shares outstanding: 100892312
Book value: 2222840243.902439
P/B ratio: 0.004389440416869431
Market cap (USD): 9757024.806829268
Debt to equity: 0.020134644261434364
Effective tax rate (%): 0.9119990157177571
COGS to revenue (%): 0
SG&A to revenue (%): 2.8188149928708466
Free cash flow (dilution-adjusted): 44993902.439024396
Buyback yield (%): 1234.7826429237034
Receivables turnover: 13.12146145557841
Capitalized R&D asset: 0
FCF margin (%): 27.542420328911522
Rule of 40 score: 27.542420328911522